Literature DB >> 1829582

Estimation of morbid risk and age at onset with missing information.

L A Cupples1, N Risch, L A Farrer, R H Myers.   

Abstract

Investigators of genetic illnesses are currently employing life-table techniques to estimate the lifetime risk of disease and the age-at-onset distribution. This methodology assumes that onset ages are known for affected individuals and that censoring ages are known for unaffected individuals. We extend these methods to incorporate affected individuals with unknown onset ages and unaffected persons with unknown censoring ages and illustrate how conventional life-table methods can produce seriously biased estimates, particularly of lifetime risk. The methodology is not restricted to genetic illnesses and can be applied to more complex illnesses with unknown etiology. We present an example for Huntington disease, which is generally assumed to be a Mendelian autosomal dominant disease, yielding estimates of lifetime risk of .503 +/- .70 and mean onset age of 47.7 +/- 3.1 years for offspring with a single affected parent. When conventional life-table techniques are employed, these estimates are .238 +/- .032 and 43.2 +/- 2.2.

Entities:  

Mesh:

Year:  1991        PMID: 1829582      PMCID: PMC1683228     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  Genetic tests under incomplete ascertainment.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1959-03       Impact factor: 11.025

2.  Estimating the age-at-onset function using life-table methods.

Authors:  A Chidambaram; A Chakravarti; R E Ferrell; S Iyengar
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

3.  Estimating genetic parameters of survival distributions: a multifactorial model.

Authors:  J M Meyer; L J Eaves
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

4.  Age-at-onset distribution in chronic diseases. A life table approach to analysis of family data.

Authors:  R C Elandt-Johnson
Journal:  J Chronic Dis       Date:  1973-08

5.  Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age.

Authors:  R C Mohs; J C Breitner; J M Silverman; K L Davis
Journal:  Arch Gen Psychiatry       Date:  1987-05

6.  Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations.

Authors:  J C Breitner; J M Silverman; R C Mohs; K L Davis
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

7.  A genetic model for age at onset in Huntington disease.

Authors:  L A Farrer; P M Conneally
Journal:  Am J Hum Genet       Date:  1985-03       Impact factor: 11.025

8.  Maternal factors in onset of Huntington disease.

Authors:  R H Myers; L A Cupples; M Schoenfeld; R B D'Agostino; N C Terrin; N Goldmakher; P A Wolf
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

9.  Using survival methods to estimate age-at-onset distributions for genetic diseases with an application to Huntington disease.

Authors:  L A Cupples; N C Terrin; R H Myers; R B D'Agostino
Journal:  Genet Epidemiol       Date:  1989       Impact factor: 2.135

10.  Huntington disease in Georgia: age at onset.

Authors:  P Adams; A Falek; J Arnold
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

View more
  8 in total

1.  Modeling the effects of genetic factors on late-onset diseases in cohort studies.

Authors:  Mark E Glickman; David R Gagnon
Journal:  Lifetime Data Anal       Date:  2002-09       Impact factor: 1.588

2.  Does the omission of missing information bias the estimates of age-at-onset distributions?

Authors:  M Krawczak; B Bockel
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

3.  Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4.

Authors:  V S Rao; A Cupples; C M van Duijn; A Kurz; R C Green; H Chui; R Duara; S A Auerbach; L Volicer; J Wells; C van Broeckhoven; J H Growdon; J L Haines; L A Farrer
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

4.  Estimating the probability for major gene Alzheimer disease.

Authors:  L A Farrer; L A Cupples
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

5.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

6.  Genetic transmission of Alzheimer's disease among families in a Dutch population based study.

Authors:  C M van Duijn; L A Farrer; L A Cupples; A Hofman
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

7.  Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG).

Authors:  Audrey E Hendricks; Jeanne C Latourelle; Kathryn L Lunetta; L Adrienne Cupples; Vanessa Wheeler; Marcy E MacDonald; James F Gusella; Richard H Myers
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

8.  Families Enriched for Exceptional Longevity also have Increased Health-Span: Findings from the Long Life Family Study.

Authors:  Paola Sebastiani; Fangui X Sun; Stacy L Andersen; Joseph H Lee; Mary K Wojczynski; Jason L Sanders; Anatoli Yashin; Anne B Newman; Thomas T Perls
Journal:  Front Public Health       Date:  2013-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.